Roles
- Assistant Professor
-
Biography
Dr. Jonathan Bell is an Assistant Professor of Clinical Radiation Oncology at the University of Miami Miller School of Medicine and Sylvester Comprehensive Cancer Center. He specializes in the treatment of tumors of the central nervous system (brain and spine) and head and neck.
Dr. Bell has experience treating patients using innovative technologies including intensity-modulated radiation therapy (IMRT), stereotactic body radiation therapy (SBRT), stereotactic radiosurgery (SRS), and proton therapy.
He received his MD and PhD degrees through the Medical Scientist Training Program (MSTP) at Northwestern University, where he worked in the laboratory of Dr. Leonidas Platanias. Dr. Bell completed his internship in preliminary internal medicine through the University of Chicago (NorthShore). He completed his residency training at the University of Miami/Jackson Health System and served as Chief Resident. -
Education & Training
Education
Post Graduate Training
-
Honors & Awards
-
Research Interests
Dr. Bell's research leverages novel MRI techniques to precisely define radiation therapy volumes in brain tumors, allowing for more targeted treatment and potentially reducing damage to surrounding healthy tissues. He has published numerous peer-reviewed publications aimed at improving outcomes for patients with benign and malignant brain tumors. -
Publications
Disclaimer: Information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, use this link to inform our data team. Your feedback is appreciated and helps us improve the quality of our content.
Clinical Trials
Viewing 0 of 2 clinical trials.
-
A Randomized Phase II Study De-Intensified ChemoRadiation for Early-Stage Anal Squamous Cell Carcinoma (DECREASE)
- Principal Investigator: Jonathan Bell
- Study Phase: Phase 2
- Enrollment Status: Not Accepting
-
Pilot Trial of Spectroscopic MRI-guided, Dose-Escalated Proton Radiation Therapy and Bevacizumab for Recurrent Glioblastoma
- Principal Investigator: Jonathan Bell
- Study Phase: N/A
- Enrollment Status: Open
